Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z0TU
|
|||
| Former ID |
DIB013574
|
|||
| Drug Name |
ITCA-638
|
|||
| Synonyms |
Omega DUROS, BioMedicines/ ALZA; Omega DUROS, Intarcia/ALZA; Omega IFN (sustained release), BioMedicines/ ALZA; Omega IFN (sustained release, hepatitis C), Intarcia/ALZA; Omega interferon (sustained release/subcutaneous/DUROS, hepatitis C), BioMedicines/ ALZA; Omega interferon (sustained release/subcutaneous/DUROS, hepatitis C), Intarcia/ALZA
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [1] | |
| Company |
Intarcia Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interferon-omega (IFNW1) | Target Info | Modulator | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| RIG-I-like receptor signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Interferons and viral infections. Biofactors. 2009 Jan-Feb;35(1):14-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.